狂野欧美激情性xxxx欧美I 成人性生交大片免费看中文网站I 日韩视频一区二区在线I 国产中的精品av小宝探花I 黄色国产在线I 久久精品视频在线观看I 在线天堂8√

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當前位置: 首頁 > ATCC代理 > pAV2
最近瀏覽歷史
聯系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮海區莊市街道興莊路9號
  • 創e慧谷42號樓B幢401室
pAV2
pAV2
規格:
貨期:
編號:B206397
品牌:Mingzhoubio

標準菌株
定量菌液
DNA
RNA

規格:
凍干粉
斜面
甘油
平板


產品名稱 pAV2
商品貨號 B206397
Designations pAV2
Depositors CA Laughlin
Biosafety Level 1
Vector Information
Size (kb): 8.7
Vector: pAV2 (plasmid)
Promoters: Promoter P19
Construction: pA11P.Xba, AAV genome
Marker(s):ampR
Construct size (kb): 8.7
Features: marker(s): ampR
promoter: viral P5, P19, P40
replicon: pMB1, AAV
terminator: AAV polyadenylation
Applications
contains sequence human adeno-associated virus type 2
expression vector
Comments
Restriction digests of the clone give the following sizes (kb): BglII--4.7, 3.7; EcoRI--6.6, 1.8.
pAV1 (ATCC 37215) and pAV2 (ATCC 37216) both contain the complete AAV2 genome, but in opposite orientations. The pAV2 vector has fewer polylinker sites than that of pAV1 (HindIII, ClaI, and one EcoRI site have been deleted).
Contains the complete viral genome for use in site-specific mutagenesis studies. Transfection into human 293 cells with an Ad helper virus results in infectious AAV virus particles.
Media ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
Growth Conditions
Temperature: 37.0°C
References

Laughlin CA, et al. Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 23: 65-73, 1983. PubMed: 6352411

Wondisford FE, et al. Cloning of the human thyrotropin beta-subunit gene and transient expression of biologically active human thyrotropin after gene transfection. Mol. Endocrinol. 2: 32-39, 1988. PubMed: 3398841

Shipped frozen
Shipping Information Distributed: frozen
梅經理 17280875617 1438578920
胡經理 13345964880 2438244627
周經理 17757487661 1296385441
于經理 18067160830 2088210172
沈經理 19548299266 2662369050
李經理 13626845108 972239479
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |